Kurma Partners has raised €140 million ($154 million) in the first closing of its Biofund IV, with a target of €250 million ...

The European Medicines Agency’s pharmacovigilance committee, PRAC, has started a review of medicines containing finasteride ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

Sirnaomics has entered a subscription agreement with biotech specialist Poon Hung Fai, who will acquire over 17.5 million ...

NHS England has proposed a phased rollout of Eli Lilly’s obesity injection Mounjaro (tirzepatide), prioritizing patients with ...

GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...

Aspire Pharma, a UK-based niche generics firm, has acquired all assets from Canute Pharma, expanding its product range and ...

The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...

F2G has raised $100 million to advance its lead antifungal drug, olorofim, despite a setback with the FDA requesting further ...

Japanese biopharma firm PeptiDream says that its wholly-owned PDRadiopharma subsidiary has entered into a strategic ...